APGE (Apogee Therapeutics) Total Liabilities: $37.86 Mil (As of Mar. 2026)


APGE Apogee Therapeutics Inc APGE
12 GF Score
Price $132.73
! 3 Warning Signs
View Full Analysis

What is Apogee Therapeutics Total Liabilities?

Apogee Therapeutics APGE +0.03% 12 Total Liabilities is $37.86 Mil as of Mar. 2026. GuruFocus rates APGE with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Apogee Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 was $37.86 Mil.

Apogee Therapeutics's quarterly Total Liabilities declined from Sep. 2025 ($39.82 Mil) to Dec. 2025 ($33.25 Mil) but then increased from Dec. 2025 ($33.25 Mil) to Mar. 2026 ($37.86 Mil).

Apogee Therapeutics's annual Total Liabilities increased from Dec. 2023 ($21.49 Mil) to Dec. 2024 ($37.16 Mil) but then declined from Dec. 2024 ($37.16 Mil) to Dec. 2025 ($33.25 Mil).

Apogee Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Apogee Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apogee Therapeutics Total Liabilities Chart

Apogee Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Liabilities
9.98 21.49 37.16 33.25

Apogee Therapeutics Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.80 38.37 39.82 33.25 37.86
APGE
12GF Score
Apogee Therapeutics Inc APGE
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apogee Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Apogee Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=27.906+(5.345+-8.8817841970013E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=33.25

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=937.134-903.883
=33.25

Apogee Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=32.952+(4.909+-8.8817841970013E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=37.86

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1293.654-1255.793
=37.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $37.86 Mil mean?
Apogee Therapeutics (APGE) has a Total Liabilities of $37.86 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Apogee Therapeutics and its competitors.
Is Apogee Therapeutics' Total Liabilities too high?
Apogee Therapeutics' current Total Liabilities is $37.86 Mil. Overall, Apogee Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Apogee Therapeutics' Total Liabilities compare to NUVL and CORT?
Apogee Therapeutics' Total Liabilities of $37.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Apogee Therapeutics and its competitors. Apogee Therapeutics's current Total Liabilities is $37.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apogee Therapeutics stock overvalued right now?
Apogee Therapeutics (APGE) has a current Total Liabilities of $37.86 Mil. The current Total Liabilities is $37.86 Mil. Apogee Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Apogee Therapeutics (APGE), the current Total Liabilities is $37.86 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apogee Therapeutics Business Description

Address 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, USA, 02453
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
12GF Score

Get the complete analysis for APGE

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$132.73
Price